Company Filing History:
Years Active: 2005
Title: Pierre Cornelis: Innovator in Immunology
Introduction
Pierre Cornelis is a notable inventor based in Elsene, Belgium. He has made significant contributions to the field of immunology, particularly in the development of adjuvants that enhance immune responses. His work focuses on innovative solutions that can potentially improve vaccine efficacy.
Latest Patents
Cornelis holds a patent for a "Th1 inducing natural adjuvant for heterologous antigens." This invention relates to the use of the major OprI lipoprotein to elicit a Type-1 immune response towards a heterologous antigen. Specifically, it involves the use of OprI-antigen fusion proteins to stimulate the Type-1 response. The patent also covers pharmaceutical formulations that comprise OprI and/or OprI fusion proteins, optionally combined with suitable excipients, to enhance the Th1 dependent cellular immune response. He has 1 patent to his name.
Career Highlights
Pierre Cornelis is associated with the Vlaams Interuniversitair Instituut Voor Biotechnologie, a prominent research institution in Belgium. His work at this institute has allowed him to explore various aspects of biotechnology and immunology, contributing to advancements in the field.
Collaborations
Cornelis has collaborated with notable colleagues, including Hilde Revets and Patrick De Baetselier. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Pierre Cornelis is a distinguished inventor whose work in immunology has the potential to impact vaccine development significantly. His innovative approaches to enhancing immune responses are paving the way for future advancements in the field.